OncXerna Therapeutics, Ltd.

Biotechnology company · Waltham, Massachusetts, United States

OncXerna Therapeutics, Ltd. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

OncXerna Therapeutics at a glance

Typebiotechnology company
HeadquartersWaltham, Massachusetts, United States
Earliest incorporation on record2018
SEC CIK1914838

What does OncXerna Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $30 million sold (2022).

Frequently asked questions about OncXerna Therapeutics

Where is OncXerna Therapeutics headquartered?

OncXerna Therapeutics, Ltd. is headquartered in Waltham, Massachusetts, United States.

What does OncXerna Therapeutics do?

OncXerna Therapeutics, Ltd. is a biotechnology company.

When was OncXerna Therapeutics founded?

The earliest incorporation on record for OncXerna Therapeutics, Ltd. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences